Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 1
1951 3
1953 2
1956 3
1957 8
1958 1
1960 3
1961 4
1962 1
1963 1
1964 9
1965 3
1966 4
1967 2
1968 4
1969 3
1970 1
1971 3
1972 4
1973 6
1974 5
1975 3
1977 3
1978 2
1979 9
1980 5
1981 13
1982 15
1983 19
1984 13
1985 15
1986 16
1987 19
1988 23
1989 24
1990 23
1991 20
1992 24
1993 27
1994 19
1995 25
1996 25
1997 17
1998 21
1999 27
2000 20
2001 38
2002 37
2003 38
2004 40
2005 69
2006 63
2007 81
2008 86
2009 62
2010 91
2011 106
2012 117
2013 116
2014 138
2015 145
2016 142
2017 147
2018 154
2019 183
2020 223
2021 243
2022 234
2023 208
2024 142

Text availability

Article attribute

Article type

Publication date

Search Results

3,074 results

Results by year

Filters applied: . Clear all
Page 1
Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis.
Sapienza G, Castronovo M, Tringali S, Bono R, Rotolo C, Mulè A, Calafiore V, Patti C, Agueli C, Randazzo V, Santoro A, Matranga D, Castagna L. Sapienza G, et al. Among authors: santoro a. Front Oncol. 2024 Sep 19;14:1441254. doi: 10.3389/fonc.2024.1441254. eCollection 2024. Front Oncol. 2024. PMID: 39364317 Free PMC article.
Cardiac resynchronization therapy guided by interventricular conduction delay: How to choose between biventricular pacing or conduction system pacing.
Marallo C, Landra F, Taddeucci S, Collantoni M, Martini L, Lunghetti S, Pagliaro A, Menci D, Baiocchi C, Fineschi M, Santoro A. Marallo C, et al. Among authors: santoro a. J Cardiovasc Electrophysiol. 2024 Oct 3. doi: 10.1111/jce.16433. Online ahead of print. J Cardiovasc Electrophysiol. 2024. PMID: 39363418
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves.
Mazzotta V, Mazzaferri F, Lanini S, Mirandola M, Lepri AC, Vergori A, Savoldi A, Santoro A, Maccarrone G, Mastrorosa I, Simonetti O, Zottis F, Nicastri E, Rosini G, Rovigo L, Tavernaro L, Sarmati L, Tascini C, Girardi E, Cattelan AM, Antinori A, Tacconelli E; MANTICO2/MONET study group. Mazzotta V, et al. Among authors: santoro a. J Infect. 2024 Sep 27:106294. doi: 10.1016/j.jinf.2024.106294. Online ahead of print. J Infect. 2024. PMID: 39343244 Free article.
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study.
Bai F, Santoro A, Hedberg P, Tavelli A, De Benedittis S, de Morais Caporali JF, Marinho CC, Leite AS, Santoro MM, Ceccherini Silberstein F, Iannetta M, Juozapaité D, Strumiliene E, Almeida A, Toscano C, Ruiz-Quiñones JA, Mommo C, Fanti I, Incardona F, Cozzi-Lepri A, Marchetti G; EuCARE Project. Bai F, et al. Among authors: santoro a. Viruses. 2024 Sep 23;16(9):1500. doi: 10.3390/v16091500. Viruses. 2024. PMID: 39339976 Free PMC article.
The impact of vaccine hesitancy on psychological impairment among healthcare workers in a Total Worker Health© approach.
Di Prinzio RR, Ceresi B, Arnesano G, Dosi A, Maimone M, Vacca ME, Vinci MR, Camisa V, Santoro A, Raponi M, Tomao P, Vonesch N, Moscato U, Zaffina S, Dalmasso G. Di Prinzio RR, et al. Among authors: santoro a. Front Public Health. 2024 Sep 12;12:1447334. doi: 10.3389/fpubh.2024.1447334. eCollection 2024. Front Public Health. 2024. PMID: 39328994 Free PMC article.
Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study.
Neal JW, Santoro A, Gonzalez-Cao M, Lim FL, Fang B, Gentzler RD, Goldschmidt J, Khrizman P, Proto C, Patel S, Puri S, Liu SV, Massarelli E, Williamson D, Schwickart M, Scheffold C, Andrianova S, Felip E. Neal JW, et al. Among authors: santoro a. JTO Clin Res Rep. 2024 Mar 20;5(10):100666. doi: 10.1016/j.jtocrr.2024.100666. eCollection 2024 Oct. JTO Clin Res Rep. 2024. PMID: 39318387 Free PMC article.
Peptides as modulators of FPPS enzyme: A multifaceted evaluation from the design to the mechanism of action.
Covelli V, Buonocore M, Grimaldi M, Scrima M, Santoro A, Marino C, De Simone V, van Baarle L, Biscu F, Scala MC, Sala M, Matteoli G, D'Ursi AM, Rodriquez M. Covelli V, et al. Among authors: santoro a. Eur J Med Chem. 2024 Sep 13;279:116871. doi: 10.1016/j.ejmech.2024.116871. Online ahead of print. Eur J Med Chem. 2024. PMID: 39303514 Free article.
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.
Spicer JD, Garassino MC, Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Arunachalam A, Keller SM, Samkari A, Gao S; KEYNOTE-671 Investigators. Spicer JD, et al. Lancet. 2024 Sep 28;404(10459):1240-1252. doi: 10.1016/S0140-6736(24)01756-2. Epub 2024 Sep 14. Lancet. 2024. PMID: 39288781 Clinical Trial.
3,074 results